Clinical Trials in San Francisco

Showing 381-400 of 12,991 trials

Clinical and Biological Characteristics of Hidradenitis Suppurativa

NCT03967600

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Hidradenitis Suppurativa

University of California, San Francisco1,000 participantsStarted Jul 2016

San Francisco, California, United States

SUSPENDEDPhase 1< 1 mile

Zr-89 Cimzia PET Imaging Rheumatoid Arthritis

NCT03546335

This is a single center exploratory imaging study investigating the initial application of zirconium-89 Deferoxamine B Certolizumab pegol (89Zr-DFO-CZP) PET in patients with rheumatoid arthritis. Patients with active symptoms of RA or signs on physical exam will be invited to participate for PET imaging.

Rheumatoid Arthritis

Robert Flavell, MD, PhD10 participantsStarted Oct 2018

San Francisco, California, United States

COMPLETEDNA< 1 mile

SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)

NCT05701098

The goal of this clinical trial is to test the Break Wave™ system in patients with upper urinary tract stones. The main question it aims to answer is whether the device is safe and effective in fragmenting (breaking) stones. Participants will a) undergo the Break Wave™ procedure, b) have a telehealth visit at 2 weeks, and c) return for an imaging study at approximately 10 weeks post-procedure.

Kidney StoneUrolithiasisNephrolithiasis+4 more

SonoMotion64 participantsStarted Oct 2023

San Diego, California, United States • San Francisco, California, United States • Santa Clara, California, United States +7 more locations

Clinical and Biological Characteristics of Hidradenitis Suppurativa

Zr-89 Cimzia PET Imaging Rheumatoid Arthritis

SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)

Find Trials by Condition in San Francisco

Community Health Worker Navigation to Support Mental Health

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

A Study of Psychedelics in Healthy Older Adults With Low Well-being

18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

Adaptive Deep Brain Stimulation to Improve Motor and Gait Functions in Parkinson's Disease

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS

Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health Care

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)